Hope for Motherhood: Pregnancy After Allogeneic Hematopoietic Cell Transplantation - a National Multicenter Study.


Journal

Blood
ISSN: 1528-0020
Titre abrégé: Blood
Pays: United States
ID NLM: 7603509

Informations de publication

Date de publication:
12 Jul 2024
Historique:
accepted: 16 06 2024
received: 12 03 2024
revised: 10 06 2024
medline: 15 7 2024
pubmed: 15 7 2024
entrez: 15 7 2024
Statut: aheadofprint

Résumé

Improved long-term survival rates after allogeneic hematopoietic cell transplantation (alloHCT) make family planning for young adult cancer survivors an important topic. However, treatment-related infertility risk poses challenges. To assess pregnancy and birth rates in a contemporary cohort, we conducted a national multicenter study using data from the German Transplant Registry, focusing on adult women aged 18-40 who underwent alloHCT between 2003 and 2018. Out of 2,654 transplanted women, 50 women experienced 74 pregnancies, occurring at a median of 4.7 years post-transplant. Fifty-seven of these resulted in live births (77%). The annual first birth rate among HCT recipients was 0.45% (95%CI: 0.31 - 0.59%), which is more than six times lower than in the general population. The probability of a live birth 10 years after HCT was 3.4 % (95%CI: 2.3- 4.5%). Factors associated with an increased likelihood of pregnancy were younger age at alloHCT, non-malignant transplant indications, no total-body-irradiation (TBI) or a cumulative dose of <8 Gray, and non-myeloablative/reduced-intensity conditioning. 72% of pregnancies occurred spontaneously, with assisted reproductive technologies (ART) used in the remaining cases. Preterm delivery and low birth weight were more common than in the general population. This study represents the largest dataset reporting pregnancies in a cohort of adult female alloHCT recipients. Our findings underscore a meaningful chance of pregnancy in alloHCT recipients. ART techniques are important and funding should be made available. However, the potential for spontaneous pregnancies should not be underestimated, and patients should be informed of the possibility of unexpected pregnancy despite reduced fertility. Further research is warranted to understand the impact of conditioning decisions on fertility preservation.

Identifiants

pubmed: 39007722
pii: 517008
doi: 10.1182/blood.2024024342
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 American Society of Hematology.

Auteurs

Katja Sockel (K)

University Hospital Carl Gustav Carus, TU Dresden, German Cancer Consortium (DKTK) , Dresden, Germany, Dresden, Germany.

Annika Neu (A)

Altona Children´s Hospital, Hamburg, Germany, Hamburg, Germany.

Maren Goeckenjan (M)

Department for Gynaecology and Obstetrics, University Hospital Dresden, Technische Universität Dresden, Germany, Dresden, Germany.

Markus Ditschkowski (M)

University Duisburg-Essen, Department of Hematology and Stem Cell Transplantation, University Hospital Essen, Germany, Essen, Germany.

Inken Hilgendorf (I)

University Clinic Jena, Jena, Germany.

Nicolaus Kroeger (N)

University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Francis Ayuketang Ayuk (FA)

University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Friedrich Stölzel (F)

Division of Stem Cell Transplantation and Cellular Immunotherapy, Department of Internal Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany, Germany.

Jan M Middeke (JM)

Uniklinikum Dresden, Dresden, Germany.

Matthias Eder (M)

Hannover Medical School, Hannover, Germany.

Wolfgang Andreas Bethge (WA)

Medical Center University of Tuebingen, Tuebingen, Germany.

Jürgen Finke (J)

University Medical Center and Medical Faculty, Freiburg, Freiburg, Germany.

Hartmut Bertz (H)

University of Freiburg, Medical Center, Freiburg, Germany.

Guido Kobbe (G)

Heinrich Heine University, Medical Faculty, Duesseldorf, Germany.

Martin Kaufmann (M)

Robert Bosch Hospital Stuttgart, Stuttgart, Germany.

Uwe Platzbecker (U)

University Hospital Leipzig, Department of Hematology and Cell Therapy, Leipzig, Germany.

David Beverungen (D)

University Hospital Leipzig, Department of Hematology and Cell Therapy, Leipzig, Germany.

Christoph Schmid (C)

Augsburg University Hospital and Medical Faculty, Augsburg, Alaska, Germany.

Malte von Bonin (M)

Department of Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany, Dresden, Germany.

Katharina Egger-Heidrich (K)

Universitätsklinikum Dresden, Dresden, Germany.

Lisa Heberling (L)

Department of Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany, Dresden, Germany.

Karolin Trautmann-Grill (K)

Universitätsklinikum Dresden, Dresden, Germany.

Raphael Teipel (R)

Universitätsklinikum Dresden, Dresden, Germany.

Gesine Bug (G)

Goethe University Frankfurt, Frankfurt, Germany.

Johanna Tischer (J)

Ludwig Maximilians University of Munich, Klinikum der Universität Muenchen-Grosshadern, Munich, Germany.

Alessia Fraccaroli (A)

University Hospital of Munich, Großhadern, LMU, Munich, Germany.

Matthias Alexander Fante (MA)

University Hospital Regensburg, Regensburg, Germany.

Daniel Wolff (D)

University of Regensburg Medical Center, Regensburg, Germany.

Thomas Luft (T)

University Hospital Heidelberg, Heidelberg, Germany.

Julia Winkler (J)

University Hospital Erlangen, Erlangen, Germany.

Kerstin Schäfer-Eckart (K)

Klinikum Nuernberg, Nuernberg, Germany.

Christof Scheid (C)

University Hospital Cologne, Cologne, Germany.

Udo Holtick (U)

Cologne University Hospital, Cologne, Germany.

Stefan Klein (S)

Universitaetsmedizin Mannheim, Mannheim, Germany.

Igor Blau (I)

Charité - Campus Virchow Klinikum, Berlin, Berlin, Germany.

Andreas Burchert (A)

Philipps University Marburg, Medical Center of the University Gießen and Marburg, Campus Marburg, Marburg, Germany.

Gerald Georg Wulf (GG)

University Hospital Center Goettingen, Goettingen, Germany.

Justin Hasenkamp (J)

University Medicine Goettingen.

Stephan Kaun (S)

Hematology, Oncology und Infectiology, Clinic Bremen-Mitte, Bremen, Germany, Bremen, Germany.

Christian Junghanss (C)

Rostock University Medical Center, Rostock, Germany.

Friederike Wortmann (F)

University of Schleswig-Holstein, Campus Lübeck, Lubeck, Germany.

Susann Winter (S)

University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

Helga Neidlinger (H)

German Registry for Hematopoietic Stem Cell Transplantation and Cell Therapy (DRST), Ulm, Germany.

Catrin Theuser (C)

University Hospital Carl Gustav Carus, TU Dresden, German Cancer Consortium (DKTK) , Dresden, Germany, Dresden, Germany.

Jan Beyersmann (J)

Institute of Statistics, University Ulm, Germany, Ulm, Germany.

Martin Bornhäuser (M)

University Hospital, TU Dresden, Dresden, Germany.

Sandra Schmeller (S)

Institute of Statistics, Ulm University, Germany, Ulm, Germany.

Johannes Schetelig (J)

Department of Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany, Dresden, Germany.

Classifications MeSH